CompletedPhase 4NCT02392364
Variable Interval Versus Set Interval Aflibercept for DME
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- California Retina Consultants
- Principal Investigator
- Dilsher S Dhoot, MDCalifornia Retina Consultants
- Intervention
- Intravitreal Aflibercept Injection(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2018
Study locations (2)
- California Retina Consultants - Bakersfield, Bakersfield, California, United States
- California Retina Consultants - Santa Barbara Office, Santa Barbara, California, United States
Collaborators
Regeneron Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02392364 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.